Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Foundation Medicine to Grow Clinical Testing, Pharma Business in 2018

Foundation Medicine to Grow Clinical Testing, Pharma Business in 2018

Mar 08, 2018
|
Julia Karow
Premium

NEW YORK (GenomeWeb) – Foundation Medicine expects to grow its clinical testing business this year while continuing to expand its pharma collaborations, following the anticipated final national coverage determination (NCD) for its FoundationOne CDx test by the Centers for Medicare and Medicaid Services later this month.

During a conference call yesterday to discuss the firm's fourth quarter earnings, CEO Troy Cox and CFO Jason Ryan provided an outline of the firm's plans and strategy for 2018.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Molecular Diagnostics

  1. Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings

  2. Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

  3. Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2

  4. MDxHealth 2020 Revenues Up 57 Percent

  5. Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.